Quick Answer
Adicet Bio, Inc. reported R&D Expense of $99.13 million for fiscal year 2025.
Adicet Bio, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $99.13M | -0.2% |
| 2024 | $99.32M | -6.3% |
| 2023 | $106.04M | +48.8% |
| 2022 | $71.25M | +45.6% |
| 2021 | $48.94M | +42.5% |
| 2020 | $34.33M | +44.9% |
| 2019 | $23.69M | +61.0% |
| 2018 | $14.72M | -12.6% |
| 2017 | $16.84M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $22.85M | -13.0% | -19.6% |
| June 30, 2025 | $28.42M | +9.7% | +24.6% |
| March 31, 2025 | $22.81M | -4.5% | -13.1% |
| September 30, 2024 | $26.25M | +0.3% | +1.4% |
| June 30, 2024 | $25.90M | -8.7% | +8.4% |
| March 31, 2024 | $23.90M | -10.7% | -8.7% |
| September 30, 2023 | $26.17M | +57.9% | -7.7% |
| June 30, 2023 | $28.36M | +75.3% | +6.0% |
- Adicet Bio, Inc. showed a decrease of -0.2% in R&D Expense compared to the prior fiscal year.
- Over the 2017–2025 period, Adicet Bio, Inc.’s r&d expense has grown by 488.7% (from $16.84 million to $99.13 million).
- The most recent figure is from Adicet Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: